Korea Electric Power EV/EBIT
What is the EV/EBIT of Korea Electric Power?
The EV/EBIT of Korea Electric Power is 51.32
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Utilities sector on NYSE compared to Korea Electric Power
What does Korea Electric Power do?
Korea Electric Power Corporation, better known as KEPCO or Hanjeon, is the largest electric utility in South Korea, responsible for the generation, transmission and distribution of electricity and the development of electric power projects including those in nuclear power, wind power and coal.
Companies with ev/ebit similar to Korea Electric Power
- Donegal has EV/EBIT of 50.93
- Blancco Technology Plc has EV/EBIT of 51.00
- AP Acquisition Corp has EV/EBIT of 51.14
- NVIDIA Corp has EV/EBIT of 51.15
- Alexion Pharmaceuticals has EV/EBIT of 51.25
- Tata Elxsi has EV/EBIT of 51.29
- Korea Electric Power has EV/EBIT of 51.32
- PI Industries has EV/EBIT of 51.33
- Seanergy Maritime Corp has EV/EBIT of 51.68
- Qudian Inc has EV/EBIT of 51.73
- Shilpa Medicare has EV/EBIT of 51.74
- Royal KPN NV has EV/EBIT of 51.77
- Horizon Therapeutics Plc has EV/EBIT of 51.78